Loading...

ELV ELEVANCE HEALTH INC Management Changes 8-K Filing

LVNC

LV

ELEVANCE HEALTH INC

(ELV)

2026 8-K

Financial Results Update

Earnings Guidance Affirmed

Sanctions Notification

Management Changes

Financial Results Announcement

Director Appointment

Earnings Guidance Update

Financial Results Report

Notes Offering Update

Earnings Guidance Update

Financial Statements

Earnings Releases

Financial Results

Q1 2025 Results

Investor Meetings

Financial Results

Financial Results

Results of Operations and F...

Earnings Guidance

Annual Meeting of Shareholders

Earnings Report

Earnings Guidance

Dividend Declaration

Earnings Report

Earnings Report

Medicare Advantage Star Rat...

Bylaws Amendment

Earnings Guidance

Appointment of CFO

Financial Statements

Earnings Guidance

Annual Meeting of Shareholders

Financial Results

Investor Conference

Management Change

Financial Results

External Links:

On February 26, 2026, Elevance Health, Inc. announced that Peter D. Haytaian will step down as Executive VP on May 4, 2026, transitioning to a Special Advisor role until December 31, 2026. The company reaffirms its earnings guidance for 2026 at least $22.30 per diluted share, expecting adjusted earnings to be at least $25.50 per diluted share, with a benefit expense ratio of 90.2%.

AI Assistant

ELEVANCE HEALTH INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.